NEU neuren pharmaceuticals limited

Ann: FDA approves Daybue - the first treatment for Rett syndrome, page-73

  1. 65 Posts.
    lightbulb Created with Sketch. 21
    It is not clear, however milestone increments in fee percentages are usually for amounts above milestones (eg. Sales $300M: fees $25M + $6M). The better payment is the milestone lump sum of $50M when sales achieve $250M, that is 25% of the milestone sales figure and is generous, but all lump sums are one-off.

    There will be some misalignment with 'Annual Net Sales' and 'Net Sales in one calendar year' if it goes to the market in April, so the first lump sum won't be available until the end of 2024 now.

    Great to see this product arrive with approval from Prof. Dame Brimble's experimenting ... and hopefully more associated products to come that fend off neurodegenerative disorders.
    Last edited by DMES: 13/03/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.